AKIN GUMP STRAUSS HAUER & FELD

Lobbying for CENTRIENT PHARMACEUTICALS LLC · Pharmaceutical Manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 4

Manufacturing

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Trade (domestic/foreign)

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Health Issues

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Pharmacy

Issues related to onshoring supply chains and biomanufacturing of essential medicines to the United States.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.